What did @.tatteredwizard actually say?
The creator claims you can "double, triple, quadruple" total testosterone without injections, citing a client who allegedly hit 2,300 ng/dL. They recommend enclomiphene (not clomid) as the best non-injection option for low T, explain the LH-testosterone pathway reasonably well, and push a product called "elevate T" for people with low DHEA and pregnenolone on bloodwork. They also note that estrogen management matters when using enclomiphene.
Let's be direct: some of this is grounded in real endocrinology. Some of it is marketing dressed up in clinical language. And one claim, specifically the 2,300 ng/dL figure, is either a dramatic outlier or not credible without peer-reviewed context.
Does the science back this up?
Partly. Enclomiphene's mechanism is legitimate and reasonably well-studied. The rest gets shakier fast.
Enclomiphene is the trans-isomer of clomiphene citrate. It blocks estrogen receptors in the hypothalamus, which increases GnRH pulsatility, which raises LH and FSH, which stimulates testicular testosterone production. That's real. Kim et al. (2013, Journal of Sexual Medicine) found enclomiphene raised total testosterone significantly in hypogonadal men while preserving sperm production, unlike exogenous testosterone.
But "doubling, tripling, quadrupling" total testosterone? The clinical literature does not support this as a typical outcome. The Wiehle et al. (2014, BJU International) trial showed mean testosterone rising from roughly 230 ng/dL to 400-500 ng/dL on enclomiphene. That is a meaningful increase. That is not quadrupling. A client hitting 2,300 ng/dL from enclomiphene alone would be far outside any published trial data and would itself warrant clinical investigation, not a TikTok testimonial.
The DHEA and pregnenolone supplementation angle is speculative. There is no strong randomized evidence that supplementing these hormones in men with low-normal levels reliably raises testosterone to clinically significant degrees.
What did they get wrong (or right)?
Credit where it is due: the LH sensitivity explanation is accurate, and the note that "more testosterone always means more estrogen" is a reasonable shorthand for aromatization. The creator is also right that enclomiphene has a better side-effect profile than clomiphene for most men, largely because it lacks the vision-disrupting zuclomiphene isomer.
What they got wrong: The 2,300 ng/dL claim is irresponsible. The upper limit of normal total testosterone in most lab reference ranges is 900-1,000 ng/dL. Publishing that number without context, or a disclaimer, implies this is a desirable target. It is not. Supraphysiologic testosterone carries real cardiovascular, hematologic, and hormonal risks. Fernandez-Balsells et al. (2010, Journal of Clinical Endocrinology and Metabolism) documented hematocrit elevation and polycythemia risk even in therapeutic ranges.
"Elevate T" is named and implicitly recommended here. That is a supplement, not an FDA-approved drug. Recommending a specific commercial product in the context of discussing hormonal treatment, without disclosing financial relationships, is a transparency problem. And no supplement has demonstrated the kind of hormonal shifts being claimed.
What should you actually know?
Enclomiphene is a real, studied option, but it is not approved by the FDA for male hypogonadism as of 2024. It is used off-label. That matters.
If you have low testosterone symptoms, the starting point is a proper workup: total testosterone, free testosterone, LH, FSH, SHBG, prolactin, and a complete metabolic panel. Not a supplement stack and not a TikTok protocol. The Endocrine Society clinical guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) are clear that treatment decisions should be based on confirmed biochemical hypogonadism, not symptoms alone.
Enclomiphene is genuinely useful for certain men, particularly younger men who want to preserve fertility while addressing low T. But claiming it can achieve results 2-4x above the normal physiologic ceiling without evidence is not education. It is hype.
- DHEA and pregnenolone are precursor hormones. Low levels on bloodwork do not automatically mean supplementation will raise testosterone meaningfully.
- Estrogen management on enclomiphene should happen under clinical supervision, not based on supplement company guides.
- "Safe if you read my guides" is not a safety protocol for hormonal intervention.